Status:
UNKNOWN
Diet Intervention in Food Sensitive Patients With IgA Nephropathy
Lead Sponsor:
Uppsala University Hospital
Collaborating Sponsors:
University Hospital, Linkoeping
Haukeland University Hospital
Conditions:
IGA Nephropathy
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to assess whether a tailored diet, eliminating antigens to which IgA nephropathy patients have demonstrated sensitivity, will have an effect on proteinuria, renal function...
Eligibility Criteria
Inclusion
- Above 18 years
- IgA nephropathy (IgAN), verified by biopsy
- Proteinuria \> 1 g/24 h
- Having signed informed consent form
Exclusion
- Participation in another clinical trial
- Patients with celiac disease
- Introduction of an angiotensin-converting enzyme (ACE) inhibitor or angiotensin II receptor blockers (ARB) during the last three months prior to inclusion
- Patients treated with immunosuppressive or systemic corticosteroid drugs within the last twelve months
Key Trial Info
Start Date :
September 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2012
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT01203007
Start Date
September 1 2010
End Date
March 1 2012
Last Update
September 17 2010
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Haukeland University Hospital
Bergen, Norway
2
Linköping University Hospital
Linköping, Sweden
3
Uppsala University Hospital
Uppsala, Sweden